SCHEMBL31268962

SCHEMBL31268962

CC1(Oc2ncnc3c2nc(-c2ccc(OCCC(=O)O)cc2Cl)n3Cc2cccc(Cl)c2Cl)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.36
▸ PIK3CB P42338 1/20 0.35
▸ S1PR5 Q9H228 3/20 0.34
▸ S1PR1 P21453 2/20 0.34
▸ PIK3C2B O00750 1/20 0.34
▸ CMA1 P23946 3/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ RXRG P48443 1/20 0.33
▸ CNR2 P34972 3/20 0.32
▸ CNR1 P21554 2/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ MCL1 Q07820 2/20 0.32
▸ PLA2G2A P14555 1/20 0.32
▸ SLC22A12 Q96S37 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268849 0.94 PIK3CD (0.37) PIK3CDS1PR5S1PR1RXRARXRB
SCHEMBL31269149 0.92 CNR1 (0.36) PIK3CDRXRARXRBRXRGCNR2
SCHEMBL31321937 0.90 PLA2G2A (0.40) PIK3CDRXRARXRBRXRGPDK2
SCHEMBL31269035 0.88 CNR1 (0.36) PIK3CDS1PR5CNR1PLA2G2AMEN1
SCHEMBL31269288 0.88 PLA2G2A (0.36) PIK3CDS1PR1RXRARXRBRXRG
SCHEMBL31269340 0.87 S1PR1 (0.36) PIK3CDS1PR5S1PR1PIK3C2BPLA2G2A
SCHEMBL31269325 0.86 S1PR1 (0.39) PIK3CDS1PR5S1PR1RXRARXRB
SCHEMBL30983523 0.85 PLA2G2A (0.38) PIK3CDCNR1PLA2G2A
SCHEMBL31268992 0.84 CNR1 (0.35) PIK3CDS1PR5CNR1PLA2G2AMEN1
SCHEMBL30983451 0.84 PLA2G2A (0.38) PIK3CDCNR1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback